myICD10.com Logo
chemotherapy

Wikipedia Summary

Chemotherapy (often abbreviated chemo, sometimes CTX and CTx) is the type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents or alkylating agents) in a standard regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim only to prolong life or to reduce symptoms (palliative chemotherapy)...
Related Codes (30)
Code
Description
Billable
Details
D61.810Antineoplastic chemotherapy induced pancytopenia
Type 2 Excludes (1)
D64.81Anemia due to antineoplastic chemotherapy
Type 2 Excludes (2)
D70.1Agranulocytosis secondary to cancer chemotherapy
Additional Codes (1)
P04.11Newborn affected by maternal antineoplastic chemotherapy
T45.1Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
Type 1 Excludes (2)
T45.1XPoisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
T45.1X1Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional)
T45.1X1APoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
T45.1X1DPoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter
T45.1X1SPoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
T45.1X2Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm
T45.1X2APoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
T45.1X2DPoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter
T45.1X2SPoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela
T45.1X3Poisoning by antineoplastic and immunosuppressive drugs, assault
T45.1X3APoisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
T45.1X3DPoisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter
T45.1X3SPoisoning by antineoplastic and immunosuppressive drugs, assault, sequela
T45.1X4Poisoning by antineoplastic and immunosuppressive drugs, undetermined
T45.1X4APoisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
T45.1X4DPoisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter
T45.1X4SPoisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
T45.1X5Adverse effect of antineoplastic and immunosuppressive drugs
T45.1X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5DAdverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5SAdverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X6Underdosing of antineoplastic and immunosuppressive drugs
T45.1X6AUnderdosing of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X6DUnderdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X6SUnderdosing of antineoplastic and immunosuppressive drugs, sequela

Rows per page

Page 1 of 1